Table 1
Enzymological studies
Patient no. | Tissue | Enzyme activities (mmol/min/mg protein) | Ratios | Mutation |
---|
C I | C II | C III | C IV | Mal ox | Succ ox | Succ/mal | CIV/CI | CIV/CII-CIII |
---|
1 | Muscle mitochondria |
21
| – | 1466 | 956 |
16
| 55 |
3.4
|
45.5
| 3.5 | T10158C |
Trophoblast | 25 | – | – | 271 | 9 | 14 | 1.6 | 9 | – |
2 | Muscle homogenate |
3
| 24 | 176 | 150 | – | – | – |
50
| 5.2 | T10158C |
3 | Muscle mitochondria | 46 | 110 | 1324 | 892 |
19
| 67 |
3.5
|
19.4
| 3.4 | T14487C |
4 | Muscle homogenate |
3.3
| 33 | 153 | 194 | – | – | – |
58.8
| 6.7 | T10191C |
5 | Muscle mitochondria |
30
| 166 | 1058 | 971 |
15
| 65 |
4.3
|
32.3
| 3.3 | T10191C |
6 | Muscle homogenate |
2
| 39 | 172 | 243 | – | – | – |
120
| – | T12706C |
7 | Heart homogenate | 29 | 157 | 646 | 736 | – | – | − |
25.8
| 3.3 | A13514G |
Controls | Muscle mitochondria | 45–109 | 69–268 | 823–1633 | 424–1290 | 21–54 | 33–95 | 2.0 (0.3) | 10.6 (2.0) | 3.2 (0.3) | |
Muscle homogenate | 8–32 | 18–70 | 67–268 | 86–342 | – | – | – | 10.6 (0.9) | 5.4 (0.6) |
Heart homogenate | 25–100 | 43–188 | 158–863 | 242–1105 | – | – | – | 9.0 (1.7) | 3.5 (0.4) |
Trophoblast | 24–30 | – | – | 226–272 | 8–14 | 14–21 | 1.4 (0.2) | 9.1 (0.2) | – |